Search Type: drug or dietary supplement name
Search Term: zanamivir (RELENZA)
| Worst Pills, Best Pills Newsletter Articles |
A comprehensive review of the safety
and effectiveness of this drug. If the drug is not a Do Not Use product, information
on adverse effects, drug interactions and how to use the medication are included.
Search results below include drug profiles where your selected drug is a primary subject of discussion
-
zanamivir (RELENZA)
We list this drug as Do Not Use because it is only minimally effective and can cause asthma.
Search results below include Disease and Drug Family Information where your selected drug is a primary subject of discussion
-
Antibiotics
[hide all summaries]
Antibiotics (drugs used to treat bacterial infections) are overwhelmingly misprescribed in the United States. Despite congressional hearings and numerous academic studies on this issue, it has become the general consensus that 40 to 60% of all antibiotics in this country are misprescribed. New studies continue to confirm the fact that a large proportion of antibiotic prescribing for both children and adults continues to be inappropriate.
Search
results below include Worst Pills, Best Pills Newsletter Articles where your
selected drug is a primary subject of discussion
-
An Update on H1N1 Influenza
[hide all summaries]
(December 2009)
As the H1N1 influenza continues to spread, we review the best ways to prevent the flu. We also discuss over 100 products that the Food and Drug Administration reprimanded for selling unapproved flu treatments online. -
Do Not Use! The Flu Drug Zanamivir (RELENZA) Revisited
[hide all summaries]
(January 2002)
Editor’s Note: We are reprinting our first review of zanamivir (RELENZA) that appeared in the November 1999 issue of Worst Pills, Best Pills News. Over the past two years no credible evidence has been published that would alter our view that this drug lacks meaningful therapeutic value in the treatment of influenza.
Search results below include Additional Information from Public Citizen where your selected drug is a primary subject of discussion
-
Letter to the National Institute for Clinical Excellence urging it to reconsider recommendations concerning Relenza use among people in the United Kingdom. (HRG Publication #1547)
[hide all summaries]
We are extremely concerned that the recent recommendations concerning the influenza drug zanamivir (Relenza) by the National Institute for Clinical Excellence (NICE), of which you are the Chair, will jeopardize the health of many people in the United Kingdom.
SHOW secondary search results for zanamivir (RELENZA)
Copyright © 2018 Public Citizen's Health Research Group. All rights reserved.
https://www.worstpills.org/